Pten heterozygous mice overexpressing ERG specifically in the prostate (Pten+/−;Probasin-ERG) developed prostatic adenocarcinoma, whereas Pten+/− mice only showed HGPIN lesions. This evidence concerns the gene PTEN and prostate adenocarcinoma.